Fundraising FoxGenoa Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)in
Co-investorsAbstract VenturesArtis VenturesFJ LabsJ12 VenturesStella CapitalAccel+23 more
Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.
BiotechCleantechNew MaterialsThame, GB
William Barton(Promoter)Kylie Vincent(Promoter)Holly Reeve(Executive Officer, Director)inMatthew Hodges(Executive Officer)inJose De Sousa(Director)Kevin Matthews(Director)in
Co-investorsClean Growth FundFirst Imagine!Future Planet CapitalOxford Investment Opportunity Network (OION)Oxford Technology ManagementUK Innovation & Science Seed Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.